J Willem M Nissink

Increasing the delivery of next generation therapeutics from high throughput screening libraries.

Mark J Wigglesworth, David C Murray, Carolyn J Blackett, 2015, Current opinion in chemical biology.

A new test set for validating predictions of protein–ligand interaction

Robin Taylor, J Willem M Nissink, Jason C Cole, 2002, Proteins.

Comparing protein–ligand docking programs is difficult

Robin Taylor, J Willem M Nissink, Jason C Cole, 2005, Proteins.

Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations

J Willem M Nissink, Jonathan B Baell, J. Baell, 2017, ACS chemical biology.

Analyzing compound and project progress through multi-objective-based compound quality assessment.

J Willem M Nissink, Sébastien Degorce, J. Nissink, 2013, Future medicinal chemistry.

Stratified High-Throughput Screening Sets Enable Flexible Screening Strategies from a Single Plated Collection

Stefan Schmitt, J Willem M Nissink, Sam Blackburn, 2014, Journal of biomolecular screening.

Utility of Resazurin, Horseradish Peroxidase, and NMR Assays to Identify Redox-Related False-Positive Behavior in High-Throughput Screens.

Ola Engkvist, J Willem M Nissink, Amélie Barozet, 2018, Assay and drug development technologies.

Mimicry by asx- and ST-turns of the four main types of beta-turn in proteins.

J Willem M Nissink, Frank H Allen, E James Milner-White, 2004, Protein science : a publication of the Protein Society.

Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold.

J Willem M Nissink, Jonathan B Baell, Martin J Scanlon, 2015, Journal of medicinal chemistry.